The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tolbutamide Market Research Report 2025
Synopsis
Tolbutamide (CAS 64-77-7), C12H18N2O3S, the formula weight is 270.35, and its form is white crystal powder.
The global Tolbutamide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Tolbutamide is suitable for the treatment of type 2 diabetes. Tolubutamide should be used in patients with high blood sugar after diet control and exercise therapy. Because of the mildening of tolbutamide, it is more suitable for mild and moderate elderly patients with diabetes.
This report aims to provide a comprehensive presentation of the global market for Tolbutamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tolbutamide.
Report Scope
The Tolbutamide market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tolbutamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tolbutamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pengyao Pharma
SINE
Changzhou Pharma
Changjiang Pharma
EASHU Pharma
Mylan
Sovereign
Vexxa LifeScience
Genesis Pharma
Segment by Type
Oral
Injection
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tolbutamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tolbutamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tolbutamide (CAS 64-77-7), C12H18N2O3S, the formula weight is 270.35, and its form is white crystal powder.
The global Tolbutamide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Tolbutamide is suitable for the treatment of type 2 diabetes. Tolubutamide should be used in patients with high blood sugar after diet control and exercise therapy. Because of the mildening of tolbutamide, it is more suitable for mild and moderate elderly patients with diabetes.
This report aims to provide a comprehensive presentation of the global market for Tolbutamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tolbutamide.
Report Scope
The Tolbutamide market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tolbutamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tolbutamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pengyao Pharma
SINE
Changzhou Pharma
Changjiang Pharma
EASHU Pharma
Mylan
Sovereign
Vexxa LifeScience
Genesis Pharma
Segment by Type
Oral
Injection
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tolbutamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tolbutamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tolbutamide Market Overview
1.1 Product Overview and Scope of Tolbutamide
1.2 Tolbutamide Segment by Type
1.2.1 Global Tolbutamide Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injection
1.3 Tolbutamide Segment by Application
1.3.1 Global Tolbutamide Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Tolbutamide Market Size Estimates and Forecasts
1.4.1 Global Tolbutamide Revenue 2019-2030
1.4.2 Global Tolbutamide Sales 2019-2030
1.4.3 Global Tolbutamide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tolbutamide Market Competition by Manufacturers
2.1 Global Tolbutamide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tolbutamide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tolbutamide Average Price by Manufacturers (2019-2024)
2.4 Global Tolbutamide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tolbutamide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tolbutamide, Product Type & Application
2.7 Tolbutamide Market Competitive Situation and Trends
2.7.1 Tolbutamide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tolbutamide Players Market Share by Revenue
2.7.3 Global Tolbutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tolbutamide Retrospective Market Scenario by Region
3.1 Global Tolbutamide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tolbutamide Global Tolbutamide Sales by Region: 2019-2030
3.2.1 Global Tolbutamide Sales by Region: 2019-2024
3.2.2 Global Tolbutamide Sales by Region: 2025-2030
3.3 Global Tolbutamide Global Tolbutamide Revenue by Region: 2019-2030
3.3.1 Global Tolbutamide Revenue by Region: 2019-2024
3.3.2 Global Tolbutamide Revenue by Region: 2025-2030
3.4 North America Tolbutamide Market Facts & Figures by Country
3.4.1 North America Tolbutamide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tolbutamide Sales by Country (2019-2030)
3.4.3 North America Tolbutamide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tolbutamide Market Facts & Figures by Country
3.5.1 Europe Tolbutamide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tolbutamide Sales by Country (2019-2030)
3.5.3 Europe Tolbutamide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tolbutamide Market Facts & Figures by Country
3.6.1 Asia Pacific Tolbutamide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tolbutamide Sales by Country (2019-2030)
3.6.3 Asia Pacific Tolbutamide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tolbutamide Market Facts & Figures by Country
3.7.1 Latin America Tolbutamide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tolbutamide Sales by Country (2019-2030)
3.7.3 Latin America Tolbutamide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tolbutamide Market Facts & Figures by Country
3.8.1 Middle East and Africa Tolbutamide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tolbutamide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tolbutamide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tolbutamide Sales by Type (2019-2030)
4.1.1 Global Tolbutamide Sales by Type (2019-2024)
4.1.2 Global Tolbutamide Sales by Type (2025-2030)
4.1.3 Global Tolbutamide Sales Market Share by Type (2019-2030)
4.2 Global Tolbutamide Revenue by Type (2019-2030)
4.2.1 Global Tolbutamide Revenue by Type (2019-2024)
4.2.2 Global Tolbutamide Revenue by Type (2025-2030)
4.2.3 Global Tolbutamide Revenue Market Share by Type (2019-2030)
4.3 Global Tolbutamide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tolbutamide Sales by Application (2019-2030)
5.1.1 Global Tolbutamide Sales by Application (2019-2024)
5.1.2 Global Tolbutamide Sales by Application (2025-2030)
5.1.3 Global Tolbutamide Sales Market Share by Application (2019-2030)
5.2 Global Tolbutamide Revenue by Application (2019-2030)
5.2.1 Global Tolbutamide Revenue by Application (2019-2024)
5.2.2 Global Tolbutamide Revenue by Application (2025-2030)
5.2.3 Global Tolbutamide Revenue Market Share by Application (2019-2030)
5.3 Global Tolbutamide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pengyao Pharma
6.1.1 Pengyao Pharma Corporation Information
6.1.2 Pengyao Pharma Description and Business Overview
6.1.3 Pengyao Pharma Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pengyao Pharma Tolbutamide Product Portfolio
6.1.5 Pengyao Pharma Recent Developments/Updates
6.2 SINE
6.2.1 SINE Corporation Information
6.2.2 SINE Description and Business Overview
6.2.3 SINE Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SINE Tolbutamide Product Portfolio
6.2.5 SINE Recent Developments/Updates
6.3 Changzhou Pharma
6.3.1 Changzhou Pharma Corporation Information
6.3.2 Changzhou Pharma Description and Business Overview
6.3.3 Changzhou Pharma Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Changzhou Pharma Tolbutamide Product Portfolio
6.3.5 Changzhou Pharma Recent Developments/Updates
6.4 Changjiang Pharma
6.4.1 Changjiang Pharma Corporation Information
6.4.2 Changjiang Pharma Description and Business Overview
6.4.3 Changjiang Pharma Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changjiang Pharma Tolbutamide Product Portfolio
6.4.5 Changjiang Pharma Recent Developments/Updates
6.5 EASHU Pharma
6.5.1 EASHU Pharma Corporation Information
6.5.2 EASHU Pharma Description and Business Overview
6.5.3 EASHU Pharma Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 EASHU Pharma Tolbutamide Product Portfolio
6.5.5 EASHU Pharma Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Tolbutamide Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Sovereign
6.6.1 Sovereign Corporation Information
6.6.2 Sovereign Description and Business Overview
6.6.3 Sovereign Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sovereign Tolbutamide Product Portfolio
6.7.5 Sovereign Recent Developments/Updates
6.8 Vexxa LifeScience
6.8.1 Vexxa LifeScience Corporation Information
6.8.2 Vexxa LifeScience Description and Business Overview
6.8.3 Vexxa LifeScience Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vexxa LifeScience Tolbutamide Product Portfolio
6.8.5 Vexxa LifeScience Recent Developments/Updates
6.9 Genesis Pharma
6.9.1 Genesis Pharma Corporation Information
6.9.2 Genesis Pharma Description and Business Overview
6.9.3 Genesis Pharma Tolbutamide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Genesis Pharma Tolbutamide Product Portfolio
6.9.5 Genesis Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tolbutamide Industry Chain Analysis
7.2 Tolbutamide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tolbutamide Production Mode & Process
7.4 Tolbutamide Sales and Marketing
7.4.1 Tolbutamide Sales Channels
7.4.2 Tolbutamide Distributors
7.5 Tolbutamide Customers
8 Tolbutamide Market Dynamics
8.1 Tolbutamide Industry Trends
8.2 Tolbutamide Market Drivers
8.3 Tolbutamide Market Challenges
8.4 Tolbutamide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
